371 related articles for article (PubMed ID: 24799675)
1. Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment.
Chaturvedi P; Gilkes DM; Takano N; Semenza GL
Proc Natl Acad Sci U S A; 2014 May; 111(20):E2120-9. PubMed ID: 24799675
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis.
Chaturvedi P; Gilkes DM; Wong CC; ; Luo W; Zhang H; Wei H; Takano N; Schito L; Levchenko A; Semenza GL
J Clin Invest; 2013 Jan; 123(1):189-205. PubMed ID: 23318994
[TBL] [Abstract][Full Text] [Related]
3. Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer.
Xiang L; Gilkes DM; Chaturvedi P; Luo W; Hu H; Takano N; Liang H; Semenza GL
J Mol Med (Berl); 2014 Feb; 92(2):151-64. PubMed ID: 24248265
[TBL] [Abstract][Full Text] [Related]
4. Wnt5a-Ror2 signaling in mesenchymal stem cells promotes proliferation of gastric cancer cells by activating CXCL16-CXCR6 axis.
Takiguchi G; Nishita M; Kurita K; Kakeji Y; Minami Y
Cancer Sci; 2016 Mar; 107(3):290-7. PubMed ID: 26708384
[TBL] [Abstract][Full Text] [Related]
5. Targeting FAPα-expressing tumor-associated mesenchymal stromal cells inhibits triple-negative breast cancer pulmonary metastasis.
Li X; Chen M; Lu W; Tang J; Deng L; Wen Q; Huang M; Deng R; Ye G; Ye W; Zhang D
Cancer Lett; 2021 Apr; 503():32-42. PubMed ID: 33482262
[TBL] [Abstract][Full Text] [Related]
6. Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis.
Jung Y; Kim JK; Shiozawa Y; Wang J; Mishra A; Joseph J; Berry JE; McGee S; Lee E; Sun H; Wang J; Jin T; Zhang H; Dai J; Krebsbach PH; Keller ET; Pienta KJ; Taichman RS
Nat Commun; 2013; 4():1795. PubMed ID: 23653207
[TBL] [Abstract][Full Text] [Related]
7. TNFα-exposed bone marrow-derived mesenchymal stem cells promote locomotion of MDA-MB-231 breast cancer cells through transcriptional activation of CXCR3 ligand chemokines.
Shin SY; Nam JS; Lim Y; Lee YH
J Biol Chem; 2010 Oct; 285(40):30731-40. PubMed ID: 20650898
[TBL] [Abstract][Full Text] [Related]
8. An agent-based model of triple-negative breast cancer: the interplay between chemokine receptor CCR5 expression, cancer stem cells, and hypoxia.
Norton KA; Wallace T; Pandey NB; Popel AS
BMC Syst Biol; 2017 Jul; 11(1):68. PubMed ID: 28693495
[TBL] [Abstract][Full Text] [Related]
9. The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation.
Meijer J; Ogink J; Kreike B; Nuyten D; de Visser KE; Roos E
Cancer Res; 2008 Jun; 68(12):4701-8. PubMed ID: 18559516
[TBL] [Abstract][Full Text] [Related]
10. miR-149 Suppresses Breast Cancer Metastasis by Blocking Paracrine Interactions with Macrophages.
Sánchez-González I; Bobien A; Molnar C; Schmid S; Strotbek M; Boerries M; Busch H; Olayioye MA
Cancer Res; 2020 Mar; 80(6):1330-1341. PubMed ID: 31911555
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26.
Chiu DK; Xu IM; Lai RK; Tse AP; Wei LL; Koh HY; Li LL; Lee D; Lo RC; Wong CM; Ng IO; Wong CC
Hepatology; 2016 Sep; 64(3):797-813. PubMed ID: 27228567
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models.
Wolfe AR; Trenton NJ; Debeb BG; Larson R; Ruffell B; Chu K; Hittelman W; Diehl M; Reuben JM; Ueno NT; Woodward WA
Oncotarget; 2016 Dec; 7(50):82482-82492. PubMed ID: 27756885
[TBL] [Abstract][Full Text] [Related]
13. Geminin overexpression-dependent recruitment and crosstalk with mesenchymal stem cells enhance aggressiveness in triple negative breast cancers.
Ananthula S; Sinha A; El Gassim M; Batth S; Marshall GD; Gardner LH; Shimizu Y; ElShamy WM
Oncotarget; 2016 Apr; 7(15):20869-89. PubMed ID: 26989079
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor-dependent ADAM12 expression mediates breast cancer invasion and metastasis.
Wang R; Godet I; Yang Y; Salman S; Lu H; Lyu Y; Zuo Q; Wang Y; Zhu Y; Chen C; He J; Gilkes DM; Semenza GL
Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33952697
[TBL] [Abstract][Full Text] [Related]
15. Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma.
Guo L; Cui ZM; Zhang J; Huang Y
Chin J Cancer; 2011 May; 30(5):336-43. PubMed ID: 21527066
[TBL] [Abstract][Full Text] [Related]
16. Dimethyloxalyl Glycine Regulates the HIF-1 Signaling Pathway in Mesenchymal Stem Cells.
Zhou B; Ge T; Zhou L; Jiang L; Zhu L; Yao P; Yu Q
Stem Cell Rev Rep; 2020 Aug; 16(4):702-710. PubMed ID: 32372246
[TBL] [Abstract][Full Text] [Related]
17. C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment.
Wani N; Nasser MW; Ahirwar DK; Zhao H; Miao Z; Shilo K; Ganju RK
Breast Cancer Res; 2014 May; 16(3):R54. PubMed ID: 24886617
[TBL] [Abstract][Full Text] [Related]
18. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of the pro-inflammatory chemokine CXCL16 is a common response of tumor cells to ionizing radiation.
Matsumura S; Demaria S
Radiat Res; 2010 Apr; 173(4):418-25. PubMed ID: 20334513
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis.
Wang T; Gilkes DM; Takano N; Xiang L; Luo W; Bishop CJ; Chaturvedi P; Green JJ; Semenza GL
Proc Natl Acad Sci U S A; 2014 Aug; 111(31):E3234-42. PubMed ID: 24938788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
